Meta-analysis of preclinical pharmacogenomic studies to discover robust and translatable biomarkers of drug response
- Algoritmes
- Behandeling op maat
- Betaaltitel
- Biomarker
- cfDNA
- DNA
- Educatie
- Geen onderdeel van een categorie
- GENAYA project
- Hartwig Medical Database
- Hartwig Medical Foundation
- Hergebruik data
- Innovatie
- IT
- Kwaliteit
- Lab proces
- Lerend zorgsysteem
- Medicijn
- Moleculaire diagnostiek
- OncoAct
- oncoanalyser
- OncoAnalyser Dx
- Onderzoek
- Participerende ziekenhuizen
- Pipeline
- Preventie
- Primaire Tumor Onbekend
- Uitbehandeld
- Verhalen patiënten
- Werken in de cloud
- Wetenschappelijke publicaties
- Whole genome sequencing
- Zeldzame kankers
Meta-analysis of preclinical pharmacogenomic studies to discover robust and translatable biomarkers of drug response
Petr Smirnov, Sisira Kadambat Nair, Farnoosh Abbas-Aghababazadeh, Nikta Feizi, Ian Smith, Trevor J. Pugh & Benjamin Haibe-Kains , 2022, DOI
Truncated FGFR2 is a clinically actionable oncogene in multiple cancers
Daniel Zingg, Jinhyuk Bhin, Julia Yemelyanenko, Sjors M. Kas, Frank Rolfs, Catrin Lutz, Jessica K. Lee, Sjoerd Klarenbeek, Ian M. …
Unscrambling cancer genomes via integrated analysis of structural variation and copy number
Charles Shale, Daniel L. Cameron, Jonathan Baber, Marie Wong, Mark J. Cowley, Anthony T. Papenfuss, Edwin Cuppen & Peter Priestley …
Feasibility of whole‐genome sequencing‐based tumor diagnostics in routine pathology practice
Kris G Samsom, Luuk J Schipper, Paul Roepman, Linda Jw Bosch, Ferry Lalezari, Elisabeth G Klompenhouwer, Adrianus J De Langen, …
Personalised selection of experimental treatment in patients with advanced solid cancer is feasible using whole-genome sequencing
Melinda A. Pruis, Floris H. Groenendijk, K. Sangeeta Badloe, Andrea Van Puffelen, Debbie Robbrecht, Winand N. M. Dinjens, Stefan Sleijfer, …
Genome-wide analysis of somatic noncoding mutation patterns in cancer
Felix Dietlein, Alex B. Wang, Christian Fagre, Anran Tang, Nicolle J. M. Besselink, Edwin Cuppen, Chunliang Li, Shamil R. Sunyaev, …
Substitution mutational signatures in whole-genome–sequenced cancers in the UK population
Andrea Degasperi, Xueqing Zou, Tauanne Dias Amarante, Andrea Martinez-Martinez, Gene Ching Chiek Koh, João M. L. Dias, Laura Heskin, Lucia …
Clinical Impact of Prospective Whole Genome Sequencing in Sarcoma Patients
Luuk J. Schipper, Kim Monkhorst, Kris G. Samsom, Linda J.W. Bosch, Petur Snaebjornsson, Hester Van Boven, Paul Roepman, Lizet E. …
Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial Carcinoma
J. Alberto Nakauma-González, Maud Rijnders, Job Van Riet, Michiel S. Van Der Heijden, Jens Voortman, Edwin Cuppen, Niven Mehra, Sandra …
High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer
Marta Palafox, Laia Monserrat, Meritxell Bellet, Guillermo Villacampa, Abel Gonzalez-Perez, Mafalda Oliveira, Fara Brasó-Maristany, Nusaibah Ibrahimi, Srinivasaraghavan Kannan, Leonardo Mina, …
Delivering precision oncology to patients with cancer
Joaquin Mateo, Lotte Steuten, Philippe Aftimos, Fabrice André, Mark Davies, Elena Garralda, Jan Geissler, Don Husereau, Iciar Martinez-Lopez, Nicola Normanno, …
Patients with Rare Cancers in the Drug Rediscovery Protocol (DRUP) Benefit from Genomics-Guided Treatment
Louisa R. Hoes, Jade M. Van Berge Henegouwen, Hanneke Van Der Wijngaart, Laurien J. Zeverijn, Daphne L. Van Der Velden, …
De complete DNA-test is een belangrijke stap op weg naar behandeling van vormen van kanker die nu nog niet behandeld kunnen worden met doelgerichte medicijnen.